Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Economic evaluation of nebulized magnesium sulphate in acute severe asthma in children.

Petrou S, Boland A, Khan K, Powell C, Kolamunnage-Dona R, Lowe J, Doull I, Hood K, Williamson P.

Int J Technol Assess Health Care. 2014 Oct;30(4):354-60. doi: 10.1017/S0266462314000440. Epub 2014 Nov 14.

PMID:
25394502
2.

Calprotectin and lactoferrin faecal levels in patients with Clostridium difficile infection (CDI): a prospective cohort study.

Swale A, Miyajima F, Roberts P, Hall A, Little M, Beadsworth MB, Beeching NJ, Kolamunnage-Dona R, Parry CM, Pirmohamed M.

PLoS One. 2014 Aug 29;9(8):e106118. doi: 10.1371/journal.pone.0106118. eCollection 2014.

3.

Serum mannose-binding lectin concentration, but not genotype, is associated with Clostridium difficile infection recurrence: a prospective cohort study.

Swale A, Miyajima F, Kolamunnage-Dona R, Roberts P, Little M, Beeching NJ, Beadsworth MB, Liloglou T, Pirmohamed M.

Clin Infect Dis. 2014 Nov 15;59(10):1429-36. doi: 10.1093/cid/ciu666. Epub 2014 Aug 28.

4.

A review of the handling of missing longitudinal outcome data in clinical trials.

Powney M, Williamson P, Kirkham J, Kolamunnage-Dona R.

Trials. 2014 Jun 19;15:237. doi: 10.1186/1745-6215-15-237. Review.

5.

Is the interleukin 8 promoter polymorphism rs4073/-251T >A associated with Clostridium difficile infection?

Miyajima F, Swale A, Zhang JE, Alfirevic A, Little M, Beeching NJ, Smith G, Kolamunnage-Dona R, Pirmohamed M.

Clin Infect Dis. 2014 Jun;58(12):e148-51. doi: 10.1093/cid/ciu152. Epub 2014 Mar 14.

6.

Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial.

Powell C, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, Hood K, Williamson P; MAGNETIC study group.

Lancet Respir Med. 2013 Jun;1(4):301-8. doi: 10.1016/S2213-2600(13)70037-7. Epub 2013 Apr 22. Erratum in: Lancet Respir Med. 2013 Jun;1(4):285.

PMID:
24429155
7.

MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo-controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children.

Powell CV, Kolamunnage-Dona R, Lowe J, Boland A, Petrou S, Doull I, Hood K, Williamson PR; MAGNETIC study group.

Health Technol Assess. 2013 Oct;17(45):v-vi, 1-216. doi: 10.3310/hta17450.

8.

Antidepressant medication in patients with advanced cancer--an observational study.

Lloyd-Williams M, Payne S, Reeve J, Kolamunnage Dona R.

QJM. 2013 Nov;106(11):995-1001. doi: 10.1093/qjmed/hct133. Epub 2013 Jun 3.

9.

Assessment and clinical course of hypocalcemia in critical illness.

Steele T, Kolamunnage-Dona R, Downey C, Toh CH, Welters I.

Crit Care. 2013 Jun 4;17(3):R106. doi: 10.1186/cc12756.

10.

Novel biomarker combination improves the diagnosis of serious bacterial infections in Malawian children.

Irwin AD, Marriage F, Mankhambo LA; IPD Group Study, Jeffers G, Kolamunnage-Dona R, Guiver M, Denis B, Molyneux EM, Molyneux ME, Day PJ, Carrol ED.

BMC Med Genomics. 2012 May 4;5:13. doi: 10.1186/1755-8794-5-13.

11.

A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC).

Owens L, Butcher G, Gilmore I, Kolamunnage-Dona R, Oyee J, Perkins L, Walley T, Williamson P, Wilson K, Pirmohamed M.

BMC Public Health. 2011 Jul 4;11:528. doi: 10.1186/1471-2458-11-528.

12.

Brief interventions in dependent drinkers: a comparative prospective analysis in two hospitals.

Cobain K, Owens L, Kolamunnage-Dona R, Fitzgerald R, Gilmore I, Pirmohamed M.

Alcohol Alcohol. 2011 Jul-Aug;46(4):434-40. doi: 10.1093/alcalc/agr044. Epub 2011 May 12.

13.

Depressive and manic symptoms are not opposite poles in bipolar disorder.

Johnson SL, Morriss R, Scott J, Paykel E, Kinderman P, Kolamunnage-Dona R, Bentall RP.

Acta Psychiatr Scand. 2011 Mar;123(3):206-10. doi: 10.1111/j.1600-0447.2010.01602.x. Epub 2010 Sep 5.

14.

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention.

Greenhalgh J, Bagust A, Boland A, Saborido CM, Fleeman N, McLeod C, Dundar Y, Dickson R, Proudlove C, Kolamunnage-Dona R, Fisher M.

Health Technol Assess. 2010 May;14 Suppl 1:31-8. doi: 10.3310/hta14Suppl1/05. Review.

15.

Assessing the potential for outcome reporting bias in a review: a tutorial.

Dwan K, Gamble C, Kolamunnage-Dona R, Mohammed S, Powell C, Williamson PR.

Trials. 2010 May 12;11:52. doi: 10.1186/1745-6215-11-52.

16.

Enhanced relapse prevention for bipolar disorder by community mental health teams: cluster feasibility randomised trial.

Lobban F, Taylor L, Chandler C, Tyler E, Kinderman P, Kolamunnage-Dona R, Gamble C, Peters S, Pontin E, Sellwood W, Morriss RK.

Br J Psychiatry. 2010 Jan;196(1):59-63. doi: 10.1192/bjp.bp.109.065524.

17.

Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?

Taylor J, Kolamunnage-Dona R, Marson AG, Smith PE, Aldenkamp AP, Baker GA; SANAD study group.

Epilepsia. 2010 Jan;51(1):48-56. doi: 10.1111/j.1528-1167.2009.02195.x. Epub 2009 Jul 2.

PMID:
19583779
18.

Joint modelling of longitudinal and competing risks data.

Williamson PR, Kolamunnage-Dona R, Philipson P, Marson AG.

Stat Med. 2008 Dec 30;27(30):6426-38. doi: 10.1002/sim.3451.

PMID:
18825652
19.

The influence of competing-risks setting on the choice of hypothesis test for treatment effect.

Williamson PR, Kolamunnage-Dona R, Tudur Smith C.

Biostatistics. 2007 Oct;8(4):689-94. Epub 2006 Dec 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk